Gastrointestinal Cancer Research - Penn State Cancer Institute
Gastrointestinal Cancer Research
Research into gastrointestinal cancer at Penn State Cancer Institute is conducted by our dedicated gastrointestinal cancer team. See current clinical trials and members of that team here.
Clinical Trials
Micro/nano technology for extracellular vesicle isolation and towards non-invasive pancreatic cancer diagnosis
The COVID-19 and Cancer Consortium (CCC19) Registry
Psychosocial Challenges and Educational/Occupational Aspirations of Adolescent/Young Adult Cancer Survivors
Prospective evaluation of potential effects of repeated gadoliniumbased contrast agent (GBCA) administrations of the same GBCA on motor and cognitive functions in neurologically normal adults in comparison to a non-GBCA exposed control group ODYSSEY
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US) (NRG-GI008)
Cancer biobank for developing novel diagnostic biomarkers and therapeutic targets
Measuring changes in knowledge, perception of benefit, susceptibility, severity, and self-efficacy of community outreach colorectal cancer and colorectal cancer screening education in underserved populations: a survey study.
A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients With Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur) A022101
A Phase III Trial Of Perioperative Versus Adjuvant Chemotherapy For Resectable Pancreatic Cancer
Disease Team Members
| First Name | Last Name | Title | Role | ||
|---|---|---|---|---|---|
 |
Amanda | Cooper | MD | ||
 |
Walter | Koltun | MD | ||
 |
Abraham | Mathew | MD | ||
 |
Matthew | Moyer | MS, MD | ||
 |
Nabeel | Sarwani | MD | ||
 |
Ian | Schreibman | MD | ||
 |
Jeffrey | Scow | MD | ||
 |
Leonard | Tuanquin | MD | ||
 |
Nelson Shu-Sang | Yee | MD, PhD, RPh |
Research into gastrointestinal cancer at Penn State Cancer Institute is conducted by our dedicated gastrointestinal cancer team. See current clinical trials and members of that team here.
Micro/nano technology for extracellular vesicle isolation and towards non-invasive pancreatic cancer diagnosis
The COVID-19 and Cancer Consortium (CCC19) Registry
Psychosocial Challenges and Educational/Occupational Aspirations of Adolescent/Young Adult Cancer Survivors
Prospective evaluation of potential effects of repeated gadoliniumbased contrast agent (GBCA) administrations of the same GBCA on motor and cognitive functions in neurologically normal adults in comparison to a non-GBCA exposed control group ODYSSEY
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US) (NRG-GI008)
Cancer biobank for developing novel diagnostic biomarkers and therapeutic targets
Measuring changes in knowledge, perception of benefit, susceptibility, severity, and self-efficacy of community outreach colorectal cancer and colorectal cancer screening education in underserved populations: a survey study.
A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients With Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur) A022101
A Phase III Trial Of Perioperative Versus Adjuvant Chemotherapy For Resectable Pancreatic Cancer
| First Name | Last Name | Title | Role | ||
|---|---|---|---|---|---|
|
Amanda | Cooper | MD | ||
|
Walter | Koltun | MD | ||
|
Abraham | Mathew | MD | ||
|
Matthew | Moyer | MS, MD | ||
|
Nabeel | Sarwani | MD | ||
|
Ian | Schreibman | MD | ||
|
Jeffrey | Scow | MD | ||
|
Leonard | Tuanquin | MD | ||
|
Nelson Shu-Sang | Yee | MD, PhD, RPh |